03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Tanya Wroblewski: no photograph is held, so the academic plate is shown instead.
Academic
Tanya Wroblewski
M.D., director of the division of nonmalignant hematology within the FDA's Center for Drug Evaluation and Research
Aug 2026Sept 2026Oct 2026Nov 2026to date
1
Quoted in the press, across 1 topic since 29 Aug 2026
02 Quoted on · 1 of 29 topics
Tanya Wroblewski: key facts
- Kind of voice
- Academic
- Role
- M.D., director of the division of nonmalignant hematology within the FDA's Center for Drug Evaluation and Research
- Quoted on
- Cancer
- Press coverage
- Quoted in the press
- Most recently quoted
- 29 Aug 2026
04 On the record · press
What Tanya Wroblewski has said
By outlet · bar length shows relative volume
- fiercepharma.com
Where Tanya Wroblewski has been quoted
- Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia verafiercepharma.com · 29 Aug 2026
How we found the articles that name Tanya Wroblewski: we searched news for these terms.
- cancer
- cancer treatment
- cancer screening
- cancer waiting times
- oncology
- chemotherapy
- radiotherapy
- cancer diagnosis
Also searched with “cancer” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Cancer
Verbatim
“People living with polycythemia vera have long faced the challenge of managing a chronic blood disorder with frequent blood draws to help address the consequences of the red blood cell overproduction. Today's approval of Mimrylo offers a new, first-in-class option that has the potential to meaningfully reduce patient burden.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.